Episode 54

Transitioning Eye Doctors from Clinical Practice to Clinical Development and Insights on Training and Development Required for a Successful Career Transition to the Industry

by Ophthalmology Business Academy | November 29, 2023

As a busy eye surgeon, you may wonder how you can actively participate in clinical development and earn extra income. In this episode, Dr. Nnenna Ihekoromadu, Founder & CEO of Ocular CRC, offers valuable perspectives on the shift from clinical practices to clinical development for doctors while highlighting the benefits you can receive from such a transition.

Questions discussed in this episode

  • 00:01:07 – Dr. Ihekoromadu’s story in ophthalmology 
  • 00:03:08 – Most Ophthalmologists and Optometrists are aware of the opportunities in the industry for doctors but don’t really know the differences. Since you have such diverse experience working in different roles in the Ophthalmology biotech and pharma space, which job will you recommend for a typical eye doctor and why? 
  • 00:09:17 – What does a typical Medical Director for Clinical Development do on a daily basis?
  • 00:11:55 – Is it worth the trouble? Why transition? What are the benefits of working in Biopharma clinical development versus patient care? 
  • 00:15:51 – What type of training or career development exists for an eye doctor who is ready to transition over an extended period of time from clinical practice to a part-time or even full-time job in pharmaceutical clinical development?
  • 00:17:47 – How did you become a Consultant, and how can an eye doctor interested in transitioning to a clinical pharma career eventually become a Consultant?

Listen to this Episode on

Nnenna Ihekoromadu, MD

Founder & CEO Ocular CRC

Dr. Ihekoromadu is a physician with over 22 years experience in Ophthalmology drug development. As the founder and CEO of Ocular CRC, she is the Principal Medical Consultant for different Ophthalmology sponsors, and the Executive Coach and Mentor for Ocular CRC College Courses. As VP of Clinical Research & Medical Affairs for AGTC, she led the Clinical Affairs, Medical Affairs, Drug Safety, Pharmacovigilance, Data Management and Biostatistics teams to successfully advance the XLRP and Achromatopsia gene therapy programs.

Nnenna also successfully held different leadership roles in multiple Ophthalmology clinical programs at Syneos Health/INC Research Business Unit, Santen Pharmaceuticals, Bausch & Lomb Pharmaceuticals and ISTA Pharmaceuticals. Her career in Pharmaceuticals which started in 2000 with Johnson & Johnson OrthoMcNeil has excelled tremendously through a unique combination of outstanding medical, scientific, business and leadership skills. Being a strategic thinker with strong analytical skills, perseverance and drive, she has successfully launched multiple new products, led the clinical development of multiple ocular drugs and interfaced with the US FDA, Japanese PMDA and other regulatory authorities. Dr. Ihekoromadu gained her Ophthalmology clinical experience from UCLA, Jules Stein Eye Institute, and her Medical Degree from University of Nigeria.

Connect with the Dr. Ihekoromadu

LinkedIn: linkedin.com/in/nnennai
Website: www.ocularcrc.com


Share this Podcast: